US4605661A
(en)
*
|
1984-06-18 |
1986-08-12 |
Eli Lilly And Company |
Aromastase inhibiting α,α-diarylimidazole-4(5)-propionitriles, α,α-diarylimidazole-4(5)-propionamides, and 4(5)-(2,2-diarylethyl)imidazoles
|
EP0225292A3
(en)
|
1985-12-06 |
1988-11-30 |
Ciba-Geigy Ag |
Certain n-substituted butyramide derivatives
|
DE3811574A1
(de)
*
|
1988-03-31 |
1989-10-19 |
Schering Ag |
N-substituierte imidazole, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
|
DE4138042C2
(de)
|
1991-11-19 |
1993-10-14 |
Biotechnolog Forschung Gmbh |
Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel
|
NZ511762A
(en)
|
1993-07-19 |
2003-09-26 |
Univ British Columbia |
Anti-angiogenic compositions and methods of use
|
US20030203976A1
(en)
|
1993-07-19 |
2003-10-30 |
William L. Hunter |
Anti-angiogenic compositions and methods of use
|
US5886026A
(en)
|
1993-07-19 |
1999-03-23 |
Angiotech Pharmaceuticals Inc. |
Anti-angiogenic compositions and methods of use
|
JP4183099B2
(ja)
|
1995-11-17 |
2008-11-19 |
ゲゼルシャフト・フュア・ビオテヒノロジッシェ・フォルシュング・ミット・ベシュレンクテル・ハフツング(ゲー・ベー・エフ) |
エポチロンcおよびd、製造法ならびに組成物
|
DE19607702A1
(de)
|
1996-02-29 |
1997-09-04 |
Biotechnolog Forschung Gmbh |
Heterozyklische Verbindungen, Herstellungsverfahren und Mittel
|
US6441025B2
(en)
|
1996-03-12 |
2002-08-27 |
Pg-Txl Company, L.P. |
Water soluble paclitaxel derivatives
|
CA2250295C
(en)
|
1996-03-12 |
2008-12-30 |
Pg-Txl Company L.P. |
Water soluble paclitaxel prodrugs
|
US20040106985A1
(en)
|
1996-04-26 |
2004-06-03 |
Jang G. David |
Intravascular stent
|
US5917084A
(en)
|
1996-07-03 |
1999-06-29 |
Millennium Pharmaceuticals, Inc. |
Antifungal agents
|
US5969145A
(en)
|
1996-08-30 |
1999-10-19 |
Novartis Ag |
Process for the production of epothilones and intermediate products within the process
|
DE19636343C1
(de)
|
1996-08-30 |
1997-10-23 |
Schering Ag |
Zwischenprodukte innerhalb der Totalsynthese von Epothilon A und B
|
DE19645361A1
(de)
|
1996-08-30 |
1998-04-30 |
Ciba Geigy Ag |
Zwischenprodukte innerhalb der Totalsynthese von Epothilon A und B, Teil II
|
DE19645362A1
(de)
|
1996-10-28 |
1998-04-30 |
Ciba Geigy Ag |
Verfahren zur Herstellung von Epothilon A und B und Derivaten
|
DE19638870B4
(de)
|
1996-09-23 |
2009-05-14 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Tubulysine, Verfahren zu ihrer Gewinnung und sie enthaltende Mittel
|
CN100344627C
(zh)
*
|
1996-11-18 |
2007-10-24 |
生物技术研究有限公司(Gbf) |
埃坡霉素c、其制备方法以及作为细胞抑制剂和植物保护剂的应用
|
US6204388B1
(en)
|
1996-12-03 |
2001-03-20 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
US6867305B2
(en)
*
|
1996-12-03 |
2005-03-15 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
WO1999001124A1
(en)
|
1996-12-03 |
1999-01-14 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto, analogues and uses thereof
|
US6660758B1
(en)
|
1996-12-13 |
2003-12-09 |
The Scripps Research Institute |
Epothilone analogs
|
US6380394B1
(en)
|
1996-12-13 |
2002-04-30 |
The Scripps Research Institute |
Epothilone analogs
|
DE19701758A1
(de)
|
1997-01-20 |
1998-07-23 |
Wessjohann Ludgar A Dr |
Epothilone-Synthesebausteine
|
CZ298027B6
(cs)
|
1997-02-25 |
2007-05-30 |
Gesellschaft Fuer Biotechnologische Forschung Mbh(Gbf) |
Zpusob prípravy epothilon-N-oxidu a N-oxidy epothilonu
|
US20020086812A1
(en)
|
1997-03-04 |
2002-07-04 |
Schweinfest Clifford W. |
Methods and compositions for diagnosis and treatment of cancer
|
DE19713970B4
(de)
|
1997-04-04 |
2006-08-31 |
R&D-Biopharmaceuticals Gmbh |
Epothilone-Synthesebausteine II - Prenylderivate
|
EP0975622B1
(de)
|
1997-04-18 |
2002-10-09 |
Studiengesellschaft Kohle mbH |
Selektive olefinmetathese von bi- oder polyfunktionellen substraten in komprimiertem kohlendioxid als reaktionsmedium
|
DE19849464A1
(de)
|
1997-04-30 |
2000-04-27 |
Schering Ag |
Wirkstofffreisetzende Stents, Verfahren zu ihrer Herstellung und ihre Verwendung zur Restenoseprophylaxe
|
US6117659A
(en)
|
1997-04-30 |
2000-09-12 |
Kosan Biosciences, Inc. |
Recombinant narbonolide polyketide synthase
|
DE19821954A1
(de)
|
1997-05-15 |
1998-11-19 |
Biotechnolog Forschung Gmbh |
Verfahren zur Herstellung eines Epothilon-Derivats
|
DE19720312A1
(de)
|
1997-05-15 |
1998-11-19 |
Hoechst Ag |
Zubereitung mit erhöhter in vivo Verträglichkeit
|
US20030049841A1
(en)
|
1997-06-16 |
2003-03-13 |
Short Jay M. |
High throughput or capillary-based screening for a bioactivity or biomolecule
|
DE19726627A1
(de)
|
1997-06-17 |
1998-12-24 |
Schering Ag |
Zwischenprodukte, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Epothilon
|
US6605599B1
(en)
*
|
1997-07-08 |
2003-08-12 |
Bristol-Myers Squibb Company |
Epothilone derivatives
|
ES2184307T3
(es)
|
1997-07-16 |
2003-04-01 |
Schering Ag |
Derivados de tiazol, procedimiento para su preparacion y su utilizacion.
|
DE19735575A1
(de)
|
1997-08-09 |
1999-02-11 |
Schering Ag |
Neue (C13-C15)-Fragmente, Verfahren zur Herstellung und ihre Verwendung zur Synthese von Epothilon und Epothilonderivaten
|
DE19813821A1
(de)
|
1998-03-20 |
1999-09-23 |
Schering Ag |
Verfahren zur Herstellung von C1-C6-Bausteinen zur Totalsynthese von Epothilon und Epothilon-Derivaten
|
DE19735578A1
(de)
|
1997-08-09 |
1999-02-11 |
Schering Ag |
Neue (C1-C6)-Fragmente, Verfahren zur Herstellung und ihre Verwendung zur Synthese von Epothilon und Epothilonderivaten
|
DE19735574A1
(de)
|
1997-08-09 |
1999-02-11 |
Schering Ag |
Neue [C1(Carboxa)-C6]-Fragmente, Verfahren zu ihrer Herstellung und ihre Verwendung zur Synthese von Epothilon und Epothilonderivaten
|
AU9340998A
(en)
|
1997-08-09 |
1999-03-01 |
Schering Aktiengesellschaft |
New epothilone derivatives, method for producing same and their pharmaceutical use
|
DE19749717A1
(de)
|
1997-10-31 |
1999-05-06 |
Schering Ag |
Neue C1-C6-Bausteine zur Totalsynthese neuer Epothilon-Derivate sowie Verfahren zur Herstellung dieser Bausteine
|
DE19751200A1
(de)
|
1997-11-13 |
1999-05-20 |
Schering Ag |
Neue Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
|
DE19744135C1
(de)
|
1997-09-29 |
1999-03-25 |
Schering Ag |
Beschichtete medizinische Implantate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Restenoseprophylaxe
|
US6320045B1
(en)
|
1997-12-04 |
2001-11-20 |
Bristol-Myers Squibb Company |
Process for the reduction of oxiranyl epothilones to olefinic epothilones
|
US6365749B1
(en)
|
1997-12-04 |
2002-04-02 |
Bristol-Myers Squibb Company |
Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
|
US6096757A
(en)
|
1998-12-21 |
2000-08-01 |
Schering Corporation |
Method for treating proliferative diseases
|
US6280999B1
(en)
|
1998-01-23 |
2001-08-28 |
Kosan Bioscience |
Sorangium polyketide synthases and encoding DNA therefor
|
US6090601A
(en)
|
1998-01-23 |
2000-07-18 |
Kosan Bioscience |
Sorangium polyketide synthase
|
US6683100B2
(en)
|
1999-01-19 |
2004-01-27 |
Novartis Ag |
Organic compounds
|
AR017979A1
(es)
|
1998-02-05 |
2001-10-24 |
Novartis Ag |
Formulaciones farmaceuticas de epotilonas, metodo para su preparacion y el uso de los mismos para la manufactura de un medicamento
|
DE19804673A1
(de)
|
1998-02-06 |
1999-08-12 |
Studiengesellschaft Kohle Mbh |
Verfahren zur Darstellung makrocyclischer Produkte durch ringschliessende Diin-Metathese
|
US6194181B1
(en)
|
1998-02-19 |
2001-02-27 |
Novartis Ag |
Fermentative preparation process for and crystal forms of cytostatics
|
IL138113A0
(en)
|
1998-02-25 |
2001-10-31 |
Sloan Kettering Inst Cancer |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
FR2775187B1
(fr)
|
1998-02-25 |
2003-02-21 |
Novartis Ag |
Utilisation de l'epothilone b pour la fabrication d'une preparation pharmaceutique antiproliferative et d'une composition comprenant l'epothilone b comme agent antiproliferatif in vivo
|
US6302838B1
(en)
|
1998-02-25 |
2001-10-16 |
Novartis Ag |
Cancer treatment with epothilones
|
US6399638B1
(en)
|
1998-04-21 |
2002-06-04 |
Bristol-Myers Squibb Company |
12,13-modified epothilone derivatives
|
US6498257B1
(en)
|
1998-04-21 |
2002-12-24 |
Bristol-Myers Squibb Company |
2,3-olefinic epothilone derivatives
|
US6407103B2
(en)
|
1998-04-21 |
2002-06-18 |
Bristol-Myers Squibb Pharma Company |
Indeno [1,2-c] pyrazol-4-ones and their uses
|
JPH11322611A
(ja)
*
|
1998-05-14 |
1999-11-24 |
Sankyo Co Ltd |
抗ウイルス剤
|
GB9810659D0
(en)
|
1998-05-18 |
1998-07-15 |
Ciba Geigy Ag |
Organic compounds
|
DE19826988A1
(de)
|
1998-06-18 |
1999-12-23 |
Biotechnolog Forschung Gmbh |
Epothilon-Nebenkomponenten
|
US6121029A
(en)
|
1998-06-18 |
2000-09-19 |
Novartis Ag |
Genes for the biosynthesis of epothilones
|
DE19923001A1
(de)
|
1999-05-13 |
2000-11-16 |
Schering Ag |
Epothilon-Derivate, Verfahren zu deren Herstellung, Zwischenprodukte und ihre pharmazeutische Verwendung
|
DE19830060A1
(de)
|
1998-06-30 |
2000-02-10 |
Schering Ag |
Epothilon-Derivate, Verfahren zu deren Herstellung, Zwischenprodukte und ihre pharmazeutische Verwendung
|
WO2000001838A2
(en)
|
1998-07-02 |
2000-01-13 |
The Board Of Regents Of The Leland Stanford Junior University |
Methods for making polyketides
|
US20030199535A1
(en)
|
1998-07-30 |
2003-10-23 |
Claudio Cavazza |
Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent
|
NZ510819A
(en)
|
1998-10-02 |
2004-03-26 |
Kosan Biosciences Inc |
Polyketide synthase enzymes and recombinant DNA constructs therefor
|
DE19846493A1
(de)
|
1998-10-09 |
2000-04-13 |
Biotechnolog Forschung Gmbh |
DNA-Sequenzen für die enzymatische Synthese von Polyketid- oder Heteropolyketidverbindungen
|
DE19848306A1
(de)
|
1998-10-14 |
2000-04-20 |
Schering Ag |
Verfahren zur Herstellung von Epothilon B und Derivaten sowie Zwischenprodukte für dieses Verfahren
|
CA2347412A1
(en)
|
1998-10-29 |
2000-05-11 |
Kosan Biosciences, Inc. |
Recombinant oleandolide polyketide synthase
|
US6303767B1
(en)
|
1998-11-05 |
2001-10-16 |
Kosan Biosciences, Inc. |
Nucleic acids encoding narbonolide polyketide synthase enzymes from streptomyces narbonensis
|
US6410301B1
(en)
|
1998-11-20 |
2002-06-25 |
Kosan Biosciences, Inc. |
Myxococcus host cells for the production of epothilones
|
KR100716272B1
(ko)
|
1998-11-20 |
2007-05-09 |
코산 바이오사이언시즈, 인코포레이티드 |
에포틸론 및 에포틸론 유도체의 생산을 위한 재조합 방법 및 물질
|
EP1140944B1
(en)
|
1998-12-22 |
2003-08-27 |
Novartis AG |
Epothilone derivatives and their use as antitumor agents
|
US6780620B1
(en)
|
1998-12-23 |
2004-08-24 |
Bristol-Myers Squibb Company |
Microbial transformation method for the preparation of an epothilone
|
US6419692B1
(en)
|
1999-02-03 |
2002-07-16 |
Scimed Life Systems, Inc. |
Surface protection method for stents and balloon catheters for drug delivery
|
US6596875B2
(en)
*
|
2000-02-07 |
2003-07-22 |
James David White |
Method for synthesizing epothilones and epothilone analogs
|
KR100718616B1
(ko)
|
1999-02-18 |
2007-05-16 |
바이엘 쉐링 파마 악티엔게젤샤프트 |
16-할로겐-에포틸론 유도체, 그 제조 방법 및 제약학적 용도
|
DE19954230A1
(de)
|
1999-11-04 |
2001-11-15 |
Schering Ag |
16-Halogen-Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
|
DE19908760A1
(de)
|
1999-02-18 |
2000-08-24 |
Schering Ag |
Neue Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
|
CA2358925C
(en)
|
1999-02-18 |
2010-04-20 |
Oxigene, Inc. |
Compositions and methods for use in targeting vascular destruction
|
US6406722B1
(en)
|
1999-02-18 |
2002-06-18 |
Robert G. Gallaher |
Method of treating viral infections and lesions with taxane compounds
|
DE19908767A1
(de)
|
1999-02-18 |
2000-10-19 |
Schering Ag |
Neue Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
|
DE19908763A1
(de)
|
1999-02-18 |
2000-08-24 |
Schering Ag |
Neue Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
|
DE19908765A1
(de)
|
1999-02-18 |
2000-08-24 |
Schering Ag |
16-Halogen-Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
|
NZ513629A
(en)
|
1999-02-22 |
2004-01-30 |
Bristol Myers Squibb Co |
C-21 modified epothilones
|
DE19907588A1
(de)
|
1999-02-22 |
2000-08-24 |
Biotechnolog Forschung Gmbh |
C-21 Modifizierte Epothilone
|
DE19930111A1
(de)
|
1999-07-01 |
2001-01-04 |
Biotechnolog Forschung Gmbh |
C-21 Modifizierte Epothilone
|
US20020058286A1
(en)
|
1999-02-24 |
2002-05-16 |
Danishefsky Samuel J. |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
US6291684B1
(en)
|
1999-03-29 |
2001-09-18 |
Bristol-Myers Squibb Company |
Process for the preparation of aziridinyl epothilones from oxiranyl epothilones
|
US6211412B1
(en)
|
1999-03-29 |
2001-04-03 |
The University Of Kansas |
Synthesis of epothilones
|
US6603015B2
(en)
|
1999-03-29 |
2003-08-05 |
University Of Kansas |
Synthesis of epothilones
|
DE60013347T2
(de)
|
1999-04-06 |
2005-09-08 |
Seiko Epson Corp. |
Tintenzusammensetzung enthaltend einen Kupferkomplex-Farbstoff
|
US6664288B1
(en)
|
1999-04-14 |
2003-12-16 |
Dana Farber Cancer Institute, Inc. |
Method and composition for the treatment of cancer
|
US7125875B2
(en)
|
1999-04-15 |
2006-10-24 |
Bristol-Myers Squibb Company |
Cyclic protein tyrosine kinase inhibitors
|
IL144910A0
(en)
|
1999-04-15 |
2002-06-30 |
Bristol Myers Squibb Co |
Cyclic compounds and pharmaceutical compositions containing the same
|
DE10015836A1
(de)
|
2000-03-27 |
2001-10-11 |
Schering Ag |
6-Alkenyl- und 6-Alkinyl-Epothilon-Derivate, Verfahren zu deren Herstellung sowie ihre Verwendung in pharmazeutischen Präparaten
|
DE19954228A1
(de)
|
1999-11-04 |
2001-09-13 |
Schering Ag |
6-Alkenyl-und 6-Alkinyl-Epothilon-Derivate, Verfahren zu deren Herstellung sowie ihre Verwendung in pharmazeutischen Präparaten
|
JP4707240B2
(ja)
*
|
1999-05-05 |
2011-06-22 |
アベンティス・フアーマ・リミテッド |
細胞接着調節剤としての尿素
|
KR100621185B1
(ko)
|
1999-09-09 |
2006-09-06 |
삼성전자주식회사 |
디디씨 모니터의 동작 기록형 마이크로컴퓨터의 제어방법
|
US6569867B2
(en)
|
1999-10-01 |
2003-05-27 |
Kosan Biosciences, Inc. |
Polyketide derivatives
|
US20020147197A1
(en)
|
1999-10-08 |
2002-10-10 |
Newman Michael J. |
Methods and compositions for enhancing pharmaceutical treatments
|
US20030054977A1
(en)
|
1999-10-12 |
2003-03-20 |
Cell Therapeutics, Inc. |
Manufacture of polyglutamate-therapeutic agent conjugates
|
US20020045220A1
(en)
|
1999-10-13 |
2002-04-18 |
Chaitan Khosla |
Biosynthesis of polyketide synthase substrates
|
CN1086389C
(zh)
*
|
1999-11-12 |
2002-06-19 |
中国科学院上海有机化学研究所 |
异埃坡霉素及合成方法
|
US20030036177A1
(en)
|
2002-08-13 |
2003-02-20 |
Joachim Strohhacker |
Single colonies of myxobacteria cells
|
AU2001243372A1
(en)
|
2000-03-01 |
2001-09-12 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
US6518421B1
(en)
|
2000-03-20 |
2003-02-11 |
Bristol-Myers Squibb Company |
Process for the preparation of epothilone analogs
|
US6593115B2
(en)
|
2000-03-24 |
2003-07-15 |
Bristol-Myers Squibb Co. |
Preparation of epothilone intermediates
|
TWI310684B
(en)
|
2000-03-27 |
2009-06-11 |
Bristol Myers Squibb Co |
Synergistic pharmaceutical kits for treating cancer
|
DE10020517A1
(de)
|
2000-04-19 |
2001-10-25 |
Schering Ag |
Neue Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
|
DE10020899A1
(de)
|
2000-04-20 |
2001-10-25 |
Schering Ag |
9-Oxa-Epothilon-Derivate, Verfahren zu deren Herstellung sowie ihre Verwendung in pharmazeutischen Präparaten
|
US6489314B1
(en)
|
2001-04-03 |
2002-12-03 |
Kosan Biosciences, Inc. |
Epothilone derivatives and methods for making and using the same
|
US6998256B2
(en)
|
2000-04-28 |
2006-02-14 |
Kosan Biosciences, Inc. |
Methods of obtaining epothilone D using crystallization and /or by the culture of cells in the presence of methyl oleate
|
US6589968B2
(en)
|
2001-02-13 |
2003-07-08 |
Kosan Biosciences, Inc. |
Epothilone compounds and methods for making and using the same
|
AU2001261121A1
(en)
|
2000-05-02 |
2001-11-12 |
Kosan Biosciences, Inc. |
Overproduction hosts for biosynthesis of polyketides
|
AU2001266583A1
(en)
|
2000-05-26 |
2001-12-11 |
Kosan Biosciences, Inc. |
Epothilone derivatives and methods for making and using the same
|
WO2002008440A2
(en)
|
2000-07-25 |
2002-01-31 |
Kosan Biosciences, Inc. |
Fermentation process for epothilones
|
JP2004520008A
(ja)
|
2000-08-09 |
2004-07-08 |
コーサン バイオサイエンシーズ, インコーポレイテッド |
ポリケチドの化学合成において使用するための生物中間体
|
UA75365C2
(en)
|
2000-08-16 |
2006-04-17 |
Bristol Myers Squibb Co |
Epothilone analog polymorph modifications, a method for obtaining thereof (variants), a pharmaceutical composition based thereon
|
WO2002016395A1
(en)
*
|
2000-08-18 |
2002-02-28 |
The Board Of Trustees Of The University Of Illinois |
Prodrugs of betulinic acid derivatives for the treatment of cancer and hiv
|
US7766956B2
(en)
|
2000-09-22 |
2010-08-03 |
Boston Scientific Scimed, Inc. |
Intravascular stent and assembly
|
US6989450B2
(en)
|
2000-10-13 |
2006-01-24 |
The University Of Mississippi |
Synthesis of epothilones and related analogs
|
AU2002221693A1
(en)
|
2000-10-16 |
2002-04-29 |
Morphochem Ag |
Epothilone synthesis components iii and iv: asymmetrically substituted acyloins and acyloin derivatives, method for the production thereof and method for the production of epithilone b, d and epothilone derivatives
|
DE10051136A1
(de)
|
2000-10-16 |
2002-04-18 |
Ludger A Wessjohann |
Epothilone-Synthesebausteine III und Verfahren zur Herstellung von Epothilon B, D und Epothilonderivaten
|
WO2002058694A2
(en)
|
2000-11-07 |
2002-08-01 |
Dana-Farber Cancer Institute, Inc. |
Method of treating hematologic tumors and cancers using beta lapachone
|
US7070797B2
(en)
|
2000-11-07 |
2006-07-04 |
Dana Farber Cancer Institute, Inc. |
Method of treating hematologic tumors and cancers
|
WO2002042432A2
(en)
|
2000-11-22 |
2002-05-30 |
Novartis Ag |
Epothilone resistant cell lines
|
GB0029895D0
(en)
*
|
2000-12-07 |
2001-01-24 |
Novartis Ag |
Organic compounds
|
HU229349B1
(en)
|
2001-01-25 |
2013-11-28 |
Bristol Myers Squibb Co |
Methods for preparation of pharmaceutical composition containing epothilone analogs useful for treatment of cancer
|
WO2002058699A1
(en)
|
2001-01-25 |
2002-08-01 |
Bristol-Myers Squibb Company |
Pharmaceutical forms of epothilones for oral administration
|
EP1353667A1
(en)
|
2001-01-25 |
2003-10-22 |
Bristol-Myers Squibb Company |
Parenteral formulations containing epothilone analogs
|
US20030004338A1
(en)
|
2001-02-01 |
2003-01-02 |
Li Wen Sen |
Process for the preparation of epothilone analogs
|
US6893859B2
(en)
|
2001-02-13 |
2005-05-17 |
Kosan Biosciences, Inc. |
Epothilone derivatives and methods for making and using the same
|
CN1774253A
(zh)
|
2001-02-20 |
2006-05-17 |
布里斯托尔-迈尔斯斯奎布公司 |
用环氧丙酯酮衍生物治疗顽固性肿瘤
|
EE200300397A
(et)
|
2001-02-20 |
2003-12-15 |
Bristol-Myers Squibb Company |
Epotilooni derivaadid refraktaarsete kasvajate raviks
|
DE60232719D1
(de)
|
2001-02-27 |
2009-08-06 |
Novartis Ag |
Kombination enthaltend einen inhibitor der signaltransduktion und ein epothilonderivat
|
DE60213884T2
(de)
|
2001-02-27 |
2007-02-22 |
GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) |
Verfahren zur Herstellung von Epothilonen
|
US7312237B2
(en)
|
2001-03-14 |
2007-12-25 |
Bristol-Myers Squibb Co. |
Combination of epothilone analogs and chemotherapeutic agents for the treatment of prolilferative diseases
|
ES2318001T3
(es)
|
2001-03-19 |
2009-05-01 |
Novartis Ag |
Combinaciones que comprenden un agente antidiarreico y una epotilona o un derivado de epotilona.
|
US20020169125A1
(en)
|
2001-03-21 |
2002-11-14 |
Cell Therapeutics, Inc. |
Recombinant production of polyanionic polymers and uses thereof
|
CA2441484A1
(en)
|
2001-03-23 |
2002-10-03 |
Napro Biotherapeutics, Inc. |
Molecular conjugates for use in treatment of cancer
|
US7081454B2
(en)
|
2001-03-28 |
2006-07-25 |
Bristol-Myers Squibb Co. |
Tyrosine kinase inhibitors
|
US6900214B2
(en)
|
2001-03-29 |
2005-05-31 |
Bristol-Myers Squibb Company |
Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
|
EP1610751A4
(en)
|
2001-04-26 |
2006-05-24 |
Univ Texas |
AGENTE / LIGAND CONJUGATED THERAPEUTIC COMPOSITIONS, METHODS OF SYNTHESIS AND USE THEREOF
|
US6906188B2
(en)
|
2001-04-30 |
2005-06-14 |
State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University |
Method for synthesizing epothilones and epothilone analogs
|
US20030023082A1
(en)
|
2001-05-15 |
2003-01-30 |
Gary Ashley |
Epothilone derivatives and methods for making and using the same
|
WO2002098868A1
(en)
|
2001-06-01 |
2002-12-12 |
Bristol-Myers Squibb Company |
Epothilone derivatives
|
ATE489080T1
(de)
|
2001-06-25 |
2010-12-15 |
Ajinomoto Kk |
Antitumorale mittel
|
DE10138347A1
(de)
|
2001-08-03 |
2003-02-27 |
Schering Ag |
Geschützte 3,5-Dihydroxy-2,2-dimethyl-valeronitrile für die Synthese von Epothilonen- und Derivaten und Verfahren zur Herstellung
|
US6933385B2
(en)
|
2001-08-03 |
2005-08-23 |
Schering Ag |
Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for the production and the use
|
US6872715B2
(en)
|
2001-08-06 |
2005-03-29 |
Kosan Biosciences, Inc. |
Benzoquinone ansamycins
|
ATE409473T1
(de)
|
2001-08-23 |
2008-10-15 |
Novartis Pharma Gmbh |
Cyclopropyl und cyclobutyl epothilon analoge
|
PL368035A1
(en)
|
2001-08-31 |
2005-03-21 |
Bristol-Myers Squibb Company |
Compositions and methods for the treatment of cancer
|
EP1423381B1
(en)
|
2001-09-06 |
2007-01-03 |
Schering Corporation |
17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
|
WO2003022844A2
(en)
*
|
2001-09-06 |
2003-03-20 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones intermediates thereto and analogues thereof
|
WO2003029195A1
(fr)
|
2001-09-28 |
2003-04-10 |
Sumika Fine Chemicals Co., Ltd. |
Intermediaires pour l'elaboration d'un derive de l'epothilone, et leur procede de production
|
TW200300350A
(en)
|
2001-11-14 |
2003-06-01 |
Bristol Myers Squibb Co |
C-5 modified indazolylpyrrolotriazines
|
US20030134883A1
(en)
|
2001-11-26 |
2003-07-17 |
David Myles |
14-Methyl-epothilones
|
CN1849122A
(zh)
|
2001-12-03 |
2006-10-18 |
先灵公司 |
Fpt抑制剂与至少两种抗肿瘤药在治疗癌症中的用途
|
DE10164592A1
(de)
|
2001-12-21 |
2003-07-03 |
Schering Ag |
C1-C6-Epothilon-Fragmente und Verfahren für die Herstellung von C1-C6-Fragmenten von Epothilonen und deren Derivaten
|
US6884608B2
(en)
|
2001-12-26 |
2005-04-26 |
Bristol-Myers Squibb Company |
Compositions and methods for hydroxylating epothilones
|
TW200303202A
(en)
|
2002-02-15 |
2003-09-01 |
Bristol Myers Squibb Co |
Method of preparation of 21-amino epothilone derivatives
|
EP1340498A1
(en)
|
2002-03-01 |
2003-09-03 |
Schering Aktiengesellschaft |
Use of epothilones in the treatment of brain diseases associated with proliferative processes
|
WO2003074521A1
(en)
|
2002-03-01 |
2003-09-12 |
University Of Notre Dame |
Derivatives of epothilone b and d and synthesis thereof
|
EP1483267A2
(en)
|
2002-03-07 |
2004-12-08 |
The Board Of Trustees Of The University Of Illinois |
Microtubule stabilizing compounds
|
ES2337134T3
(es)
|
2002-03-12 |
2010-04-21 |
Bristol-Myers Squibb Company |
Derivados de c3-ciano-epotilona.
|
AU2003218107A1
(en)
|
2002-03-12 |
2003-09-29 |
Bristol-Myers Squibb Company |
C12-cyano epothilone derivatives
|
US6900208B2
(en)
|
2002-03-28 |
2005-05-31 |
Bristol Myers Squibb Company |
Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
|
TW200400191A
(en)
|
2002-05-15 |
2004-01-01 |
Bristol Myers Squibb Co |
Pharmaceutical compositions and methods of using C-21 modified epothilone derivatives
|
US20040072882A1
(en)
|
2002-05-20 |
2004-04-15 |
Kosan Biosciences, Inc., A Delaware Corporation |
Methods to administer epothilone D
|
AU2003243561A1
(en)
|
2002-06-14 |
2003-12-31 |
Bristol-Myers Squibb Company |
Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
|
TW200401638A
(en)
|
2002-06-20 |
2004-02-01 |
Bristol Myers Squibb Co |
Heterocyclic inhibitors of kinases
|
DE10232094A1
(de)
|
2002-07-15 |
2004-02-05 |
GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) |
5-Thiaepothilone und 15-disubstituierte Epothilone
|
TWI329112B
(en)
|
2002-07-19 |
2010-08-21 |
Bristol Myers Squibb Co |
Novel inhibitors of kinases
|
EP1524979A2
(en)
|
2002-07-31 |
2005-04-27 |
Schering AG |
New effector conjugates, process for their production and their pharmaceutical use
|
AU2003266961A1
(en)
|
2002-08-02 |
2004-02-25 |
Novartis Ag |
Epothilone derivatives
|
WO2004013145A1
(en)
|
2002-08-02 |
2004-02-12 |
Bristol-Myers Squibb Company |
Pyrrolotriazine kinase inhibitors
|
AU2003260723A1
(en)
|
2002-08-17 |
2004-03-03 |
The Queens Universlty Of Belfast |
Use of vinca alkaloyds, taxane, cryptophycine, ephitoline or eleutherobine for treating alzheimer
|
EP1391213A1
(en)
|
2002-08-21 |
2004-02-25 |
Boehringer Ingelheim International GmbH |
Compositions and methods for treating cancer using maytansinoid CD44 antibody immunoconjugates and chemotherapeutic agents
|
US20040126379A1
(en)
|
2002-08-21 |
2004-07-01 |
Boehringer Ingelheim International Gmbh |
Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and chemotherapeutic agents
|
WO2004018635A2
(en)
|
2002-08-21 |
2004-03-04 |
Kosan Biosciences, Inc. |
Myxococcus xanthus bacteriophage mx9 transformation and integration system
|
US7649006B2
(en)
|
2002-08-23 |
2010-01-19 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
PT1767535E
(pt)
|
2002-08-23 |
2010-02-24 |
Sloan Kettering Inst Cancer |
Síntese de epotilonas, respectivos intermediários, análogos e suas utilizações
|
US6921769B2
(en)
|
2002-08-23 |
2005-07-26 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
CA2495913A1
(en)
|
2002-08-23 |
2004-03-04 |
Medigene Oncology Gmbh |
Non-vesicular cationic lipid formulations
|
JP2006500391A
(ja)
|
2002-09-04 |
2006-01-05 |
シェーリング コーポレイション |
サイクリン依存性キナーゼインヒビターとしてのピラゾロピリミジン
|
ATE376548T1
(de)
|
2002-09-04 |
2007-11-15 |
Schering Corp |
Pyrazolopyrimidine als hemmstoffe cyclin- abhängiger kinasen
|
US20040043089A1
(en)
|
2002-09-04 |
2004-03-04 |
Rabie A-Bakr M |
Buguzhi agent and composition and methods of preparing and administering the same
|
ES2285164T3
(es)
|
2002-09-04 |
2007-11-16 |
Schering Corporation |
Pirazolopirimidinas como inhibidores de quinasas dependientes de ciclina.
|
DE60313872T2
(de)
|
2002-09-04 |
2008-01-17 |
Schering Corp. |
Pyrazoloä1,5-aüpyrimidine als hemmstoffe cyclin-abhängiger kinasen
|
GB0221312D0
(en)
|
2002-09-13 |
2002-10-23 |
Novartis Ag |
Organic compounds
|
AU2003267129A1
(en)
|
2002-09-16 |
2004-04-30 |
Agcert International, Llc |
Food-borne pathogen and spoilage detection device and method
|
AR041292A1
(es)
|
2002-09-19 |
2005-05-11 |
Schering Corp |
Pirazolopiridinas como inhibidores de quinasa dependientes de ciclina
|
CN100549011C
(zh)
|
2002-09-19 |
2009-10-14 |
先灵公司 |
用作细胞周期蛋白依赖性激酶抑制剂的新颖咪唑并吡啶
|
DE10244847A1
(de)
|
2002-09-20 |
2004-04-01 |
Ulrich Prof. Dr. Speck |
Medizinische Vorrichtung zur Arzneimittelabgabe
|
KR20060010709A
(ko)
|
2002-09-23 |
2006-02-02 |
쉐링 코포레이션 |
사이클린 의존성 키나제 억제제로서의 신규한 이미다조피라진
|
EP1543008B1
(en)
|
2002-09-23 |
2007-11-07 |
Schering Corporation |
Imidazopyrazines as cyclin dependent kinase inhibitors
|
EP1542998A4
(en)
|
2002-09-23 |
2007-01-31 |
Bristol Myers Squibb Co |
PROCESS FOR THE PREPARATION, ISOLATION AND PURIFICATION OF EPOTHILON B, AND RINSE CRYSTAL STRUCTURES OF EPOTHILON B
|
US20040058899A1
(en)
|
2002-09-25 |
2004-03-25 |
Klimko Peter G. |
Use of epothilones and analogs in conjunction with ophthalmic surgery
|
AU2003275282A1
(en)
|
2002-09-30 |
2004-04-23 |
Bristol-Myers Squibb Company |
Novel tyrosine kinase inhibitors
|
TW200501960A
(en)
|
2002-10-02 |
2005-01-16 |
Bristol Myers Squibb Co |
Synergistic kits and compositions for treating cancer
|
AU2003279911A1
(en)
|
2002-10-09 |
2004-05-04 |
Kosan Biosciences, Inc. |
Therapeutic formulations
|
CA2499682A1
(en)
|
2002-10-09 |
2004-04-22 |
Kosan Biosciences, Inc. |
Epo d + 5-fu/gemcitabine
|
CA2501610C
(en)
|
2002-10-11 |
2012-01-03 |
Dana-Farber Cancer Institute Inc |
Epothilone derivatives for the treatment of multiple myeloma
|
SI1553938T1
(sl)
|
2002-10-15 |
2007-06-30 |
Univ Louisiana State |
Uporaba epotilonskih derivatov za zdravljenje hiperparatiroidizma
|
JP2006508126A
(ja)
|
2002-11-06 |
2006-03-09 |
アザヤ セラピューティクス インコーポレイティッド |
薬学的製剤のタンパク質安定化されたリポソーム製剤
|
JP4641941B2
(ja)
|
2002-11-07 |
2011-03-02 |
コーサン バイオサイエンシーズ, インコーポレイテッド |
トランス−9,10−デヒドロエポチロンcおよびd、それらのアナログ、ならびにそれらを作製する方法
|
JP2006514009A
(ja)
|
2002-11-14 |
2006-04-27 |
セルメド オンコロジー (ユーエスエイ), インコーポレイテッド |
ペプチドデホルミラーゼ活性化プロドラッグ
|
WO2004048372A1
(en)
|
2002-11-28 |
2004-06-10 |
Morphochem Ag Komb Chemie |
Thia-epothilone derivatives for the treatment of cancer
|
US8088605B2
(en)
|
2002-12-04 |
2012-01-03 |
Technologies Biolactics Inc. |
Exopolysaccharides delivery system for active molecules
|
DE10256982A1
(de)
|
2002-12-05 |
2004-06-24 |
Schering Ag |
Neue Effektor-Konjugate, Verfahren zu Ihrer Herstellung und Ihre Pharmazeutische Verwendung
|
JP2006510626A
(ja)
|
2002-12-05 |
2006-03-30 |
シエーリング アクチエンゲゼルシャフト |
増殖疾患の処理における部位特異的供給のためのエポチロン類似体
|
EP1575454A4
(en)
|
2002-12-09 |
2006-11-29 |
Medtronic Vascular Inc |
MODULAR STENT WITH POLYMER BRIDGES ON MODULAR CONTACT POINTS
|
JP2006515291A
(ja)
|
2002-12-09 |
2006-05-25 |
ノバルティス アクチエンゲゼルシャフト |
ステントに入れて狭窄症を処置するための微小管安定化剤
|
KR20190034694A
(ko)
|
2002-12-09 |
2019-04-02 |
아브락시스 바이오사이언스, 엘엘씨 |
약리학적 물질의 조성물 및 그 전달방법
|
WO2004054624A1
(en)
|
2002-12-12 |
2004-07-01 |
Conforma Therapeutics Corporation |
Cytotoxins and diagnostic imaging agents comprising hsp90 ligands
|
EP1572242B1
(en)
|
2002-12-13 |
2014-04-16 |
Immunomedics, Inc. |
Immunoconjugates with an intracellularly-cleavable linkage
|
TW200420565A
(en)
|
2002-12-13 |
2004-10-16 |
Bristol Myers Squibb Co |
C-6 modified indazolylpyrrolotriazines
|
GB0230024D0
(en)
|
2002-12-23 |
2003-01-29 |
Novartis Ag |
Organic compounds
|
EP1581539A4
(en)
|
2003-01-03 |
2007-09-19 |
Bristol Myers Squibb Co |
NEW TYROSINE KINASE HEMMER
|
AU2003219947A1
(en)
|
2003-02-26 |
2004-09-28 |
Bristol-Myers Squibb Company |
Compositions and methods for hydroxylating epothilones
|
GB0305928D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
GB0306907D0
(en)
|
2003-03-26 |
2003-04-30 |
Angiogene Pharm Ltd |
Boireductively-activated prodrugs
|
BRPI0408891A
(pt)
|
2003-03-28 |
2006-04-11 |
Kosan Biosciences Inc |
dispositivos, métodos, e composições para prevenir restenose
|